Agresta Samuel 4
4 · Foghorn Therapeutics Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Agresta Samuel
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-16$3.72/sh+311,297$1,158,025→ 311,297 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-16−311,297→ 0 totalExercise: $3.72Exp: 2029-09-16→ Common Stock (311,297 underlying) - Sale
Common Stock
2023-08-16$8.25/sh−311,297$2,568,200→ 0 total
Footnotes (1)
- [F1]The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested.